scholarly article | Q13442814 |
P819 | ADS bibcode | 1993PNAS...9011277S |
P356 | DOI | 10.1073/PNAS.90.23.11277 |
P932 | PMC publication ID | 47965 |
P698 | PubMed publication ID | 8248241 |
P5875 | ResearchGate publication ID | 14951532 |
P50 | author | Paul Greengard | Q309979 |
Tomas Hökfelt | Q2440397 | ||
Ole Petter Ottersen | Q7085927 | ||
P2093 | author name string | G L Snyder | |
V Gundersen | |||
G Fisone | |||
P Morino | |||
P2860 | cites work | Protein measurement with the Folin phenol reagent | Q20900776 |
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications | Q24561689 | ||
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 | ||
Activation of NMDA receptors induces dephosphorylation of DARPP-32 in rat striatal slices | Q28236649 | ||
DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1 | Q28259380 | ||
Evidence that type A CCK receptors facilitate dopamine efflux in rat brain | Q68021750 | ||
Neuronal localization of cholecystokinin mRNA in the rat brain by using in situ hybridization histochemistry | Q69752487 | ||
The distribution of cholecystokinin immunoreactivity in the central nervous system of the rat as determined by radioimmunoassay | Q70755496 | ||
Brain peptides as neurotransmitters | Q72614435 | ||
Cholecystokinins in the central nervous system and neurohypophysis | Q72934000 | ||
DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. I. Regional and cellular distribution in the rat brain | Q28265789 | ||
Brain CCK-B receptors mediate the suppression of dopamine release by cholecystokinin | Q28274708 | ||
Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity | Q28334293 | ||
Distinct cholecystokinin receptors in brain and pancreas | Q28366068 | ||
A dopamine- and cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions | Q28643908 | ||
Vasoactive intestinal polypeptide induces glycogenolysis in mouse cortical slices: a possible regulatory mechanism for the local control of energy metabolism | Q34054730 | ||
Endogenous dynorphins inhibit excitatory neurotransmission and block LTP induction in the hippocampus. | Q36174208 | ||
Phosphorylation of the catalytic subunit of Na+,K(+)-ATPase inhibits the activity of the enzyme | Q37647401 | ||
Quantitative electron microscopic immunocytochemistry of neuroactive amino acids | Q38364992 | ||
Immunochemical evidence of cholecystokinin-like peptides in brain | Q39414097 | ||
Peptidergic neurones | Q40097706 | ||
Amino acids in rat neostriatum: Alteration by kainic acid lesion | Q41026531 | ||
Intracellular studies on the dopamine-induced firing inhibition of neostriatal neurons in vitro: evidence for D1 receptor involvement | Q42204001 | ||
Metabolism and transport of amino acids studied by immunocytochemistry | Q42503723 | ||
DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein: regional, tissue, and phylogenetic distribution | Q42524859 | ||
An electron microscopic, immunogold analysis of glutamate and glutamine in terminals of rat spinocerebellar fibers | Q44254270 | ||
The opioid peptide dynorphin mediates heterosynaptic depression of hippocampal mossy fibre synapses and modulates long-term potentiation | Q44337992 | ||
Characterization of antisera to glutamate and aspartate | Q48162017 | ||
Selective degeneration of two out of the nine types of synapses in cat caudate nucleus after cortical lesions | Q48218279 | ||
Striatal lesions and transplants demonstrate that cholecystokinin receptors are localized on intrinsic striatal neurones: a quantitative autoradiographic study | Q48227676 | ||
Interactions between dopamine and amino acid-induced excitation and inhibition in the striatum | Q48334305 | ||
Immunohistochemical evidence for a crossed cholecystokinin corticostriatal pathway in the rat. | Q48395241 | ||
New peptide in the vertebrate CNS reacting with antigastrin antibodies | Q48435369 | ||
Phosphorylation of DARPP-32 and protein phosphatase inhibitor-1 in rat choroid plexus: regulation by factors other than dopamine | Q48449212 | ||
Studies on cholecystokinin-containing neuronal pathways in rat cerebral cortex and striatum | Q48570559 | ||
DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. III. Immunocytochemical localization. | Q48691508 | ||
Effect of cholecystokinin octapeptide on endogenous amino acid release from the rat ventromedial nucleus of the hypothalamus and striatum | Q48750236 | ||
Cholecystokinin modulates the release of dopamine from the anterior and posterior nucleus accumbens by two different mechanisms | Q48784606 | ||
Cortical neurons expressing the cholecystokinin gene in the rat: distribution in the adult brain, ontogeny, and some of their projections | Q48887576 | ||
Origin of the cholecystokinin-containing fibers in the rat caudatoputamen | Q49019094 | ||
MORFOREL, a computer program for two-dimensional analysis of micrographs of biological specimens, with emphasis on immunogold preparations | Q49162061 | ||
The actions of cholecystokinin and related peptides on pyramidal neurones of the mammalian hippocampus | Q54538986 | ||
P433 | issue | 23 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | phosphorylation | Q242736 |
cholecystokinin | Q60315441 | ||
P304 | page(s) | 11277-11281 | |
P577 | publication date | 1993-12-01 | |
P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
P1476 | title | Regulation by the neuropeptide cholecystokinin (CCK-8S) of protein phosphorylation in the neostriatum | |
P478 | volume | 90 |
Q33703262 | Beyond the dopamine receptor: the DARPP-32/protein phosphatase-1 cascade |
Q48617260 | Bidirectional regulation of DARPP-32 phosphorylation by dopamine. |
Q48678036 | Brain-derived neurotrophic factor regulates maturation of the DARPP-32 phenotype in striatal medium spiny neurons: studies in vivo and in vitro |
Q45020754 | Candidate genes, pathways and mechanisms for bipolar (manic-depressive) and related disorders: an expanded convergent functional genomics approach |
Q48120764 | Cannabinoid CB1 receptors are localized primarily on cholecystokinin-containing GABAergic interneurons in the rat hippocampal formation |
Q60050266 | Cholecystokinin B receptor antagonists enhance the locomotor response to the N-methyl-d-aspartate antagonists phencyclidine and dizocilpine maleate |
Q35639141 | DARPP-32: an integrator of neurotransmission |
Q42989363 | Dephosphorylation of Ser-137 in DARPP-32 by protein phosphatases 2A and 2C: different roles in vitro and in striatonigral neurons |
Q48849175 | Effects of secretogranin II-derived peptides on the release of neurotransmitters monitored in the basal ganglia of the rat with in vivo microdialysis |
Q48414498 | Electrical stimulation of the prefrontal cortex increases cholecystokinin, glutamate, and dopamine release in the nucleus accumbens: an in vivo microdialysis study in freely moving rats. |
Q28583839 | Immunohistochemical characterization of cholecystokinin containing neurons in the rat basolateral amygdala |
Q31031335 | Localization of the CB1 type cannabinoid receptor in the rat basolateral amygdala: high concentrations in a subpopulation of cholecystokinin-containing interneurons |
Q48388865 | Modulation of the voltage-gated sodium current in rat striatal neurons by DARPP-32, an inhibitor of protein phosphatase |
Q82029336 | Neurochemistry of Parkinson's disease |
Q35104448 | Some aspects on the anatomy and function of central cholecystokinin systems |
Q58112339 | The DARPP-32/protein phosphatase-1 cascade: a model for signal integration1Published on the World Wide Web on 22 January 1998.1 |
Q34100272 | The neurobiology of slow synaptic transmission |
Search more.